Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Amonkar

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Annals of Pharmacotherapy|March 23, 2001
Pharmacists' preferences for continuing education and certificate programsV G Scott, M M Amonkar, S S Madhavan
Current Oncology (Toronto, Ont.)|October 25, 2013
Cost-effectiveness of lapatinib plus letrozole in her2-positive, hormone receptor-positive metastatic breast cancer in CanadaT E Delea, J Amdahl, A Chit, et al.
Journal of Community Health|July 10, 1999
Barriers and facilitators to providing common preventive screening services in managed care settingsM M Amonkar, S Madhavan, S A Rosenbluth, et al.
Journal of Clinical Pharmacy and Therapeutics|June 1, 1997
The gift relationship between pharmaceutical companies and physicians: an exploratory survey of physiciansS Madhavan, M M Amonkar, D Elliott, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|September 27, 2003
Obesity and health-related quality of life: a cross-sectional analysis of the US populationM K Hassan, A V Joshi, S S Madhavan, et al.
British Journal of Cancer|August 30, 2008
Q-TWiST analysis of lapatinib combined with capecitabine for the treatment of metastatic breast cancerB Sherrill, M M Amonkar, S Stein, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 21, 2008
Impact of compliance and persistence with bisphosphonate therapy on health care costs and utilizationJ A Sunyecz, L Mucha, O Baser, et al.
Journal of Community Health|June 27, 2000
Assessing managed care's role in promoting preventive careM M Amonkar, S Madhavan, S A Rosenbluth, et al.
Current Medical Research and Opinion|September 11, 2007
Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonatesS R Earnshaw, C N Graham, B Ettinger, et al.
Breast Cancer Research and Treatment|June 11, 2010
Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancerRob Riemsma, C A Forbes, A Kessels, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Annals of Pharmacotherapy|March 23, 2001
Pharmacists' preferences for continuing education and certificate programsV G Scott, M M Amonkar, S S Madhavan
Current Oncology (Toronto, Ont.)|October 25, 2013
Cost-effectiveness of lapatinib plus letrozole in her2-positive, hormone receptor-positive metastatic breast cancer in CanadaT E Delea, J Amdahl, A Chit, et al.
Journal of Community Health|July 10, 1999
Barriers and facilitators to providing common preventive screening services in managed care settingsM M Amonkar, S Madhavan, S A Rosenbluth, et al.
Journal of Clinical Pharmacy and Therapeutics|June 1, 1997
The gift relationship between pharmaceutical companies and physicians: an exploratory survey of physiciansS Madhavan, M M Amonkar, D Elliott, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|September 27, 2003
Obesity and health-related quality of life: a cross-sectional analysis of the US populationM K Hassan, A V Joshi, S S Madhavan, et al.
British Journal of Cancer|August 30, 2008
Q-TWiST analysis of lapatinib combined with capecitabine for the treatment of metastatic breast cancerB Sherrill, M M Amonkar, S Stein, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 21, 2008
Impact of compliance and persistence with bisphosphonate therapy on health care costs and utilizationJ A Sunyecz, L Mucha, O Baser, et al.
Journal of Community Health|June 27, 2000
Assessing managed care's role in promoting preventive careM M Amonkar, S Madhavan, S A Rosenbluth, et al.
Current Medical Research and Opinion|September 11, 2007
Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonatesS R Earnshaw, C N Graham, B Ettinger, et al.
Breast Cancer Research and Treatment|June 11, 2010
Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancerRob Riemsma, C A Forbes, A Kessels, et al.
Pageof 2